Special Issue "Major Breakthroughs in Diabetic Animal Model Research"
Deadline for manuscript submissions: 31 January 2024 | Viewed by 881
Interests: diabetic autonomic neuropathy; animal models; cardiac innervation; neuropeptides
Diabetes mellitus is one of the most significant global health emergencies of the 21st century. According to a statistical analysis conducted by International Diabetes Federation in 2017, 451 million adult people have diabetes worldwide, and this number is expected to reach 693 million by 2045. WHO claimed that it will be the seventh leading cause of death worldwide in 2030. For these reasons, it is necessary to pay great attention to research on the processes occurring in the diabetic organism. Although research into the pathophysiology of this disease has been ongoing for more than 100 years, no effective and reliable therapy has yet been found. Animal models of individual types of diabetes played, and still play, a significant role in this research.
The aim of this Special Issue is to collect the recent updates on the use of animal models in diabetes research, including, the description of hitherto undescribed pathological processes or new therapeutic options. We welcome original research and review articles.
Potential topics include, but are not limited to, the following:
- Genetic or spontaneously induced animal models of type 1 or type 2 diabetes;
- Nongenetic or experimentally induced animal models of type 1 or type 2 diabetes;
- Animal models of gestational diabetes mellitus (GDM);
- iPSC-based in vitro diabetic models;
- Stem-cell-based organ-on-a-chip diabetic models;
- Animal models of diabetic complications;
- Future perspectives of modeling diabetes mellitus in animals;
- Diabetic biomarkers;
- Recent advances in treating diabetes and its complications from nonclinical studies;
- Conventional and complementary approaches;
- Vascular damage and regeneration.
Dr. Magdalena Chottova Dvorakova
Dr. Shashank Pandey
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- type 1 diabetes mellitus
- type 2 diabetes mellitus
- gestational diabetes
- animal models
- diabetic neuropathy
- diabetic retinopathy
- diabetic nephropathy
- targeted therapy
- stem cell technology